全文获取类型
收费全文 | 1727篇 |
免费 | 116篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 45篇 |
儿科学 | 23篇 |
妇产科学 | 59篇 |
基础医学 | 283篇 |
口腔科学 | 16篇 |
临床医学 | 126篇 |
内科学 | 549篇 |
皮肤病学 | 33篇 |
神经病学 | 76篇 |
特种医学 | 76篇 |
外科学 | 223篇 |
综合类 | 9篇 |
预防医学 | 32篇 |
眼科学 | 28篇 |
药学 | 77篇 |
中国医学 | 1篇 |
肿瘤学 | 203篇 |
出版年
2024年 | 6篇 |
2023年 | 46篇 |
2022年 | 83篇 |
2021年 | 138篇 |
2020年 | 67篇 |
2019年 | 67篇 |
2018年 | 73篇 |
2017年 | 51篇 |
2016年 | 49篇 |
2015年 | 59篇 |
2014年 | 52篇 |
2013年 | 69篇 |
2012年 | 97篇 |
2011年 | 108篇 |
2010年 | 53篇 |
2009年 | 39篇 |
2008年 | 75篇 |
2007年 | 69篇 |
2006年 | 74篇 |
2005年 | 57篇 |
2004年 | 66篇 |
2003年 | 69篇 |
2002年 | 49篇 |
2001年 | 25篇 |
2000年 | 35篇 |
1999年 | 24篇 |
1998年 | 15篇 |
1997年 | 13篇 |
1996年 | 10篇 |
1995年 | 6篇 |
1994年 | 7篇 |
1993年 | 5篇 |
1992年 | 17篇 |
1991年 | 17篇 |
1990年 | 16篇 |
1989年 | 21篇 |
1988年 | 13篇 |
1987年 | 13篇 |
1986年 | 11篇 |
1985年 | 12篇 |
1984年 | 15篇 |
1983年 | 7篇 |
1979年 | 6篇 |
1978年 | 5篇 |
1974年 | 6篇 |
1973年 | 5篇 |
1970年 | 6篇 |
1969年 | 3篇 |
1968年 | 5篇 |
1960年 | 3篇 |
排序方式: 共有1859条查询结果,搜索用时 78 毫秒
41.
Hiromu Moriyama Moeko Tsutsuura Nana Kojima Yuki Mizukami Sho Tashiro Sumika Osa Yuki Enoki Kazuaki Taguchi Kazutaka Oda Satoshi Fujii Yoshiko Takahashi Yukihiro Hamada Toshimi Kimura Yoshio Takesue Kazuaki Matsumoto 《Journal of infection and chemotherapy》2021,27(5):781-785
We carried out a systematic review and meta-analysis exploring the relationship between vancomycin (VCM) trough concentrations and its effectiveness and nephrotoxicity in pediatric patients. We conducted our analysis using MEDLINE, Web of Sciences, and Cochrane Register of Controlled Trials as electronic databases (June 29, 2019). Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. We identified 16 studies that were eligible for the meta-analysis. A total of 351 and 3,266 patients were included in the analysis for effectiveness and nephrotoxicity, respectively. Pediatric MRSA infection patients with VCM trough concentrations ≥ 10 μg/mL had significantly lower treatment failure rates (OR 0.54, 95% CI 0.30–0.96). The incidence of nephrotoxicity was significantly higher in trough concentrations ≥ 15 μg/mL than when they were < 15 μg/mL (OR 3.02, 95% CI 2.08–4.38). We identified the optimal VCM trough concentrations associated with effectiveness and nephrotoxicity in pediatric patients with MRSA infection. Further prospective studies are needed to find optimal dosing and monitoring strategy on VCM in pediatric population. 相似文献
42.
Yoshiyuki Shioyama Hiroshi Tsuji Hiroaki Suefuji Makoto Sinoto Akira Matsunobu Shingo Toyama Katsumasa Nakamura Sho Kudo 《International journal of urology》2015,22(1):33-39
Recent advances in external beam radiotherapy have allowed us to deliver higher doses to the tumors while decreasing doses to the surrounding tissues. Dose escalation using high‐precision radiotherapy has improved the treatment outcomes of prostate cancer. Intensity‐modulated radiation therapy has been widely used throughout the world as the most advanced form of photon radiotherapy. In contrast, particle radiotherapy has also been under development, and has been used as an effective and non‐invasive radiation modality for prostate and other cancers. Among the particles used in such treatments, protons and carbon ions have the physical advantage that the dose can be focused on the tumor with only minimal exposure of the surrounding normal tissues. Furthermore, carbon ions also have radiobiological advantages that include higher killing effects on intrinsic radio‐resistant tumors, hypoxic tumor cells and tumor cells in the G0 or S phase. However, the degree of clinical benefit derived from these theoretical advantages in the treatment of prostate cancer has not been adequately determined. The present article reviews the available literature on the use of particle radiotherapy for prostate cancer as well as the literature on the physical and radiobiological properties of this treatment, and discusses the role and the relative merits of particle radiotherapy compared with current photon‐based radiotherapy, with a focus on proton beam therapy and carbon ion radiotherapy. 相似文献
43.
Katsuhiko Iwakiri Hidenori Kanazawa Satoshi Matsuzaka Norihiko Tada Hitoshi Saitoh Hitoshi Yoshimoto Yoshiya Nakagawa Yuuji Osada Toshiaki Sugiura Makoto Kotoyori Yasutaka Mamiya Hisagi Yamada Yoshiyuki Narahara Akihiko Kawakami Masafumi Kobayashi 《Journal of gastroenterology》1998,33(3):305-309
The effects of transjugular intrahepatic portosystemic shunt (TIPS) placement on esophageal motor function and gastroesophageal
reflux were investigated in patients with esophageal varices. In six men with esophageal varices, esophageal manometry and
upper gastrointestinal endoscopy were performed before and 15–20 days after TIPS placement. Intraesophageal pH monitoring
was performed in the four patients with severe esophageal varices (defined as the largest sized varices) following TIPS placement.
Findings were compared with those in six healthy men (controls) who underwent esophageal manometry and intraesophageal pH
monitoring. The esophageal varices resolved or were reduced after TIPS placement. Resting lower esophageal sphincter (LES)
pressures were similar in the study group before and after TIPS placement and in the control subjects. The incidence and progression
of esophageal contractions were similar in the study group before and after TIPS placement and in the control subjects. At
3 cm above the LES, the amplitude of esophageal contraction after TIPS placement was significantly higher than that before
TIPS placement. At 3 and 8 cm above the LES, the amplitude of esophageal contraction in the control subjects was significantly
higher than that in the study group before and after TIPS placement. Esophageal acid exposure time after TIPS placement was
similar to that in the controls. TIPS placement is a useful treatment that improves esophageal motor function without the
occurrence of pathologic gastroesophageal reflux.
(Received May 28, 1997; accepted Sept. 26, 1997) 相似文献
44.
Kometani K Moriyama M Nakashima Y Katayama Y Wang SF Yamasaki S Saito T Hattori M Minato N 《Blood》2008,112(12):4565-4573
We demonstrate that lck promoter-driven conditional expression of transgenic SPA-1, a Rap GTPase-activation protein, causes a profound defect of alphabeta T-cell development at the CD4/CD8 double-negative (DN) stage due to enhanced cell death without affecting gammadelta T-cell development. The effect was specific to the DN stage, because CD4 promoter-driven SPA-1 expression hardly affected T-cell development. Rap1A17, a dominant-negative Rap mutant, interfered with the generation of double-positive (DP) cells from Rag2(-/-) fetal thymocytes in vitro in the presence of anti-CD3epsilon antibody and Notch ligand. Rap GTPases were activated in a DN cell line by the expression of self-oligomerizing CD3 (CD8:CD3epsilon chimera), which substituted autonomous pre-T-cell receptor (TCR) signal, inducing CD69 expression and CD25 down-regulation. Reciprocally, expression of C3G, a Rap guanine nucleotide exchange factor, in both normal and Rag2(-/-) DN cells markedly enhanced Notch-dependent generation and expansion of DP cells without additional anti-CD3epsilon antibody, thus bypassing pre-TCR. Defective alphabeta T-cell development in the conditional SPA-1-transgenic mice was restored completely by introducing a p53(-/-) mutation. These results suggest that endogenous Rap GTPases downstream of pre-TCR play an essential role in rescuing pre-T cells from the p53-mediated checkpoint response, thus allowing Notch-mediated expansion and differentiation. 相似文献
45.
46.
47.
Yu Sawada Tetsuya Honda Sho Hanakawa Satoshi Nakamizo Teruasa Murata Yuri Ueharaguchi-Tanada Sachiko Ono Wataru Amano Saeko Nakajima Gyohei Egawa Hideaki Tanizaki Atsushi Otsuka Akihiko Kitoh Teruki Dainichi Narihito Ogawa Yuichi Kobayashi Takehiko Yokomizo Makoto Arita Motonobu Nakamura Yoshiki Miyachi Kenji Kabashima 《The Journal of experimental medicine》2015,212(11):1921-1930
Resolvin E1 (RvE1) is a lipid mediator derived from ω3 polyunsaturated fatty acids that exerts potent antiinflammatory roles in several murine models. The antiinflammatory mechanism of RvE1 in acquired immune responses has been attributed to attenuation of cytokine production by dendritic cells (DCs). In this study, we newly investigated the effect of RvE1 on DC motility using two-photon microscopy in a contact hypersensitivity (CHS) model and found that RvE1 impaired DC motility in the skin. In addition, RvE1 attenuated T cell priming in the draining lymph nodes and effector T cell activation in the skin, which led to the reduced skin inflammation in CHS. In contrast, leukotriene B4 (LTB4) induced actin filament reorganization in DCs and increased DC motility by activating Cdc42 and Rac1 via BLT1, which was abrogated by RvE1. Collectively, our results suggest that RvE1 attenuates cutaneous acquired immune responses by inhibiting cutaneous DC motility, possibly through LTB4-BLT1 signaling blockade.Following the well-known epidemiological study conducted in Northwest Greenland in the 1970s (Dyerberg et al., 1978), several clinical assessments have indicated that a diet rich in ω3 polyunsaturated fatty acids (PUFAs) has beneficial effects in various inflammatory diseases, including asthma, psoriasis, inflammatory bowel diseases, and rheumatoid arthritis (Horrobin, 1987). Although it remains unclear how ω3 PUFAs exert such antiinflammatory effects, recent studies have identified several derivatives of ω3 PUFAs that possess strong antiinflammatory effects (Serhan et al., 2008; Tull et al., 2009). Resolvin E1 (RvE1) is one such antiinflammatory lipid mediator.RvE1 is known to exert its actions through two receptors, BLT1 and ChemR23 (Arita et al., 2007). RvE1 binds to BLT1, a G protein–coupled receptor for leukotriene B4 (LTB4), and inhibits BLT1 signals (Arita et al., 2007). In addition, RvE1 exhibits an agonistic activity toward ChemR23 (Arita et al., 2007), a G protein–coupled receptor for chemerin. The antiinflammatory effects of RvE1 have been demonstrated in acute innate immune inflammation, such as peritonitis (Arita et al., 2007) and colitis (Arita et al., 2005b). In these models, RvE1 exerted its antiinflammatory effects by inhibiting neutrophil infiltration into the inflammatory foci through a blockade of LTB4-BLT1 signaling in neutrophils (Haas-Stapleton et al., 2007). In contrast, few studies have been conducted on the effect of RvE1 on acquired immune responses, in which DCs and T cells play major roles in the development. In these studies, the attenuated cytokine production, such as IL-12 and IL-23, from DCs is considered as the major mechanism by which RvE1 exerts the antiinflammatory effects (Arita et al., 2005a; Haworth et al., 2008). However, the effect of RvE1 on DC motility has not been investigated in the context of acquired immunity.In the peripheral tissues such as the skin, DCs migrate in an amoeboid movement that requires actin polymerization via activation of the Rho family of small GTPases, such as Cdc42, Rac, and Rho A (Lämmermann and Germain, 2014). In acquired immunity such as contact hypersensitivity (CHS), upon uptake of foreign antigens, DCs migrate to the draining LNs (dLNs) via lymphatic vessels to establish sensitization by inducing the antigen-specific T cell differentiation (Honda et al., 2013). In elicitation, DC migration to form DC–T cell clustering is required for efficient antigen presentation in situ (Natsuaki et al., 2014). Thus, active DC motility is an essential factor for acquired immunity.In this study, we investigated the effects and underlying mechanisms of RvE1 on DC motility using a CHS model, which is a prototype of delayed-type hypersensitivity in the skin mediated by IFN-γ (Mori et al., 2008; Honda et al., 2013). RvE1 inhibited cutaneous DC migration into the dLNs and suppressed antigen-specific T cell induction in the sensitization phase. In addition, live imaging analysis revealed that RvE1 inhibited cutaneous DC motility and cluster formation in the skin, which subsequently attenuated activation of effector T cells in the skin in the elicitation phase of CHS. Intriguingly, LTB4 induced actin filament reorganization in DCs and increased DC motility by activating Cdc42 and Rac1 via BLT1, which was abrogated by RvE1. These results suggest that RvE1 exerts its antiinflammatory effects in cutaneous acquired immunity by inhibiting DC motility, possibly through an LTB4-BLT1 signaling blockade. 相似文献
48.
Masatsugu Ohara Goki Suda Megumi Kimura Osamu Maehara Tomoe Shimazaki Taku Shigesawa Kazuharu Suzuki Akihisa Nakamura Naoki Kawagishi Masato Nakai Takuya Sho Mitsuteru Natsuizaka Kenichi Morikawa Koji Ogawa Tomoe Kobayashi Minoru Uebayashi Ryo Takagi Isao Yokota Tsuyoshi Shimamura Naoya Sakamoto 《Hepatology research》2020,50(6):715-725
49.
Sho Shirakashi Koji Yamane Hiroe Ishitani Tetsuya Yanagida Hiroshi Yokoyama 《Parasitology research》2014,113(7):2515-2524
Three species of the Kudoid parasite (Myxozoa: Multivalvulida) were observed in the somatic muscle of Japanese parrotfish Calotomus japonicus caught off the coast of western Japan. All three species formed pseudocysts in myofibers and caused subclinical infections. The three Kudoa species were distinguished by spore morphology, as well as their 18S and 28S rDNA sequences. We identified a previously undescribed taxa Kudoa igami n. sp. with spores that were stellate with rounded peripheral edges and five to six polar capsules (prevalence 29.3 %). Kudoa igami n. sp. were morphologically most similar to Kudoa neothunni but were distinguishable by a more rounded shape in the apical view. Molecular analyses demonstrated that the K. igami n. sp. is closely related to Kudoa thalassomi; however, the similarity in the 28S rDNA sequence was <96 % and the spore morphology was different. We found Kudoa thalassomi in one sample (prevalence 2.4 %), which is a new host and geographical record for this species. Kudoa lateolabracis, which causes postmortem myoliquefaction in Chinese sea bass Lateolabrax sp. and olive flounder Paralichthys olivaceus was found in Japanese parrotfish (prevalence 41.5 %) for the first time, but did not cause myoliquefaction. We also expanded the host record for the brain-infecting Kudoa yasunagai (prevalence 94.1 %). In addition, an unidentified microsporidia was observed in the somatic muscle (prevalence 23.3 %). 相似文献
50.